{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T15:25:43Z","timestamp":1764602743331},"reference-count":103,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2004,5,14]],"date-time":"2004-05-14T00:00:00Z","timestamp":1084492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Internal Medicine"],"published-print":{"date-parts":[[2004,6]]},"abstract":"<jats:title>Abstract.<\/jats:title><jats:p>Postmenopausal osteoporosis (PMO) is a common disease that will become more prevalent in the future, with costly implications for public health. Prevention of the disease and its consequences, namely fractures, is therefore, important for both the individual and society. This review discusses: the goals of PMO prevention; the identification of women at risk, including the use of bone mineral density and bone turnover markers; the relevance in the prevention setting of various current guidelines for PMO management; recent data on therapeutic options for the treatment and prevention of PMO, in particular bisphosphonates, hormone replacement therapy and several other new pharmacological agents. It concludes that it is crucial for PMO prevention to start before disease onset and that, in the light of recent evidence, the existing guidelines need updating if they are to continue to be relevant.<\/jats:p>","DOI":"10.1111\/j.1365-2796.2004.01292.x","type":"journal-article","created":{"date-parts":[[2004,5,14]],"date-time":"2004-05-14T14:42:41Z","timestamp":1084545761000},"page":"615-628","source":"Crossref","is-referenced-by-count":9,"title":["Prevention of postmenopausal osteoporosis with pharmacological therapy: practice and possibilities"],"prefix":"10.1111","volume":"255","author":[{"given":"J.\u2010Y.","family":"Reginster","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,5,14]]},"reference":[{"key":"e_1_2_23_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(91)90512-V"},{"key":"e_1_2_23_3_2","volume-title":"Assessment of Fracture Risk and Its Application to Screening for Postmenopausal Osteoporosis","author":"World Health Organization","year":"1994"},{"key":"e_1_2_23_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199208273270908"},{"key":"e_1_2_23_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650070608"},{"key":"e_1_2_23_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01623782"},{"key":"e_1_2_23_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01623352"},{"key":"e_1_2_23_8_2","doi-asserted-by":"publisher","DOI":"10.3109\/17453678208992185"},{"key":"e_1_2_23_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1990.tb01378.x"},{"key":"e_1_2_23_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08657-9"},{"key":"e_1_2_23_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)90023-1"},{"key":"e_1_2_23_12_2","first-page":"4779","volume-title":"Osteoporosis","author":"Gold DT","year":"2001"},{"key":"e_1_2_23_13_2","first-page":"1","article-title":"Osteoporosis, prevention, diagnosis, and therapy","volume":"17","year":"2000","journal-title":"NIH Consens Statement"},{"key":"e_1_2_23_14_2","first-page":"294","article-title":"2001 medical guidelines for clinical practice for the prevention and management of postmenopausal osteoporosis","volume":"7","author":"American Association of Clinical Endocrinologists","year":"2001","journal-title":"Endocr Pract"},{"key":"e_1_2_23_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001980050093"},{"key":"e_1_2_23_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.22.2815"},{"key":"e_1_2_23_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199503233321202"},{"key":"e_1_2_23_18_2","author":"National Osteoporosis Foundation","journal-title":"Physician's Guide 2002"},{"issue":"10","key":"e_1_2_23_19_2","first-page":"S1","article-title":"2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada","volume":"167","author":"Brown JP","year":"2002","journal-title":"CMAJ"},{"key":"e_1_2_23_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.312.7041.1254"},{"key":"e_1_2_23_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001980170006"},{"key":"e_1_2_23_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.303.6808.961"},{"key":"e_1_2_23_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-012470862-4\/50061-1"},{"key":"e_1_2_23_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08761-5"},{"key":"e_1_2_23_25_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.4.8415"},{"key":"e_1_2_23_26_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-199812001-00001"},{"key":"e_1_2_23_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001980050009"},{"key":"e_1_2_23_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.312.7029.482"},{"key":"e_1_2_23_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650111021"},{"key":"e_1_2_23_30_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2000.15.8.1526"},{"key":"e_1_2_23_31_2","doi-asserted-by":"publisher","DOI":"10.1210\/er.23.1.16"},{"key":"e_1_2_23_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199906)42:6<1246::AID-ANR22>3.0.CO;2-U"},{"key":"e_1_2_23_33_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.85.1.6267"},{"key":"e_1_2_23_34_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.1997.12.7.1083"},{"issue":"1","key":"e_1_2_23_35_2","first-page":"S32","article-title":"The role of markers of bone turnover in the assessment of fracture risk in postmenopausal women","volume":"8","author":"Delmas PD.","year":"1998","journal-title":"Osteoporos Int"},{"key":"e_1_2_23_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/8756-3282(95)00493-9"},{"key":"e_1_2_23_37_2","first-page":"197","volume-title":"Bone Markers: Biochemical and Clinical Perspective","author":"Johnell O","year":"2001"},{"key":"e_1_2_23_38_2","author":"Royal College of Physicians","journal-title":"Osteoporosis. Clinical Guidelines for Prevention and Treatment. Update on Pharmacological Interventions and an Algorithm for Management"},{"key":"e_1_2_23_39_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.3.321"},{"key":"e_1_2_23_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08827-X"},{"key":"e_1_2_23_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(80)92592-1"},{"key":"e_1_2_23_42_2","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1001\/jama.1996.03540170033029","article-title":"Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen\/progestin interventions (PEPI) trial. The Writing Group for the PEPI","volume":"276","year":"1996","journal-title":"JAMA"},{"key":"e_1_2_23_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1994.tb13618.x"},{"key":"e_1_2_23_44_2","doi-asserted-by":"publisher","DOI":"10.5435\/00124635-199901000-00003"},{"key":"e_1_2_23_45_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-117-1-1"},{"key":"e_1_2_23_46_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198711053171901"},{"key":"e_1_2_23_47_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01623654"},{"key":"e_1_2_23_48_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-95-1-28"},{"key":"e_1_2_23_49_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-2-7"},{"key":"e_1_2_23_50_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.22.2891"},{"key":"e_1_2_23_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-2760(99)00177-0"},{"key":"e_1_2_23_52_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.7.637"},{"key":"e_1_2_23_53_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.23.2189"},{"key":"e_1_2_23_54_2","doi-asserted-by":"publisher","DOI":"10.1210\/er.2001-4002"},{"key":"e_1_2_23_55_2","unstructured":"International Osteoporosis Foundation:http:\/\/www.bioscorpio.com."},{"key":"e_1_2_23_56_2","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2002.123938"},{"key":"e_1_2_23_57_2","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.19.1.0325"},{"key":"e_1_2_23_58_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1010002907247"},{"key":"e_1_2_23_59_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-199915040-00004"},{"key":"e_1_2_23_60_2","doi-asserted-by":"publisher","DOI":"10.1007\/PL00004164"},{"key":"e_1_2_23_61_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200161050-00013"},{"key":"e_1_2_23_62_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02242942"},{"key":"e_1_2_23_63_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.82.9.2784"},{"key":"e_1_2_23_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(93)90350-X"},{"key":"e_1_2_23_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)00278-7"},{"key":"e_1_2_23_66_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199005033221803"},{"key":"e_1_2_23_67_2","first-page":"13","article-title":"Reminder: severe oesophageal reactions with alendronate sodium (Fosamax)","volume":"24","author":"MCA\/CSM","year":"1998","journal-title":"Curr Problems Pharmacovigilance"},{"key":"e_1_2_23_68_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-131-12-199912210-00005"},{"key":"e_1_2_23_69_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.4.1492"},{"key":"e_1_2_23_70_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199802193380801"},{"key":"e_1_2_23_71_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-128-4-199802150-00001"},{"key":"e_1_2_23_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)07088-2"},{"key":"e_1_2_23_73_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.24.2077"},{"key":"e_1_2_23_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(03)00008-5"},{"key":"e_1_2_23_75_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03339822"},{"key":"e_1_2_23_76_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2000.16517"},{"key":"e_1_2_23_77_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.03258.x"},{"key":"e_1_2_23_78_2","doi-asserted-by":"publisher","DOI":"10.4065\/77.10.1031"},{"issue":"1","key":"e_1_2_23_79_2","first-page":"S403","article-title":"Risedronate prevents bone loss in early postmenopausal women","volume":"14","author":"Ebeling P","year":"1999","journal-title":"J Bone Miner Res"},{"key":"e_1_2_23_80_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.2.396"},{"key":"e_1_2_23_81_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.14.1344"},{"key":"e_1_2_23_82_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001980050010"},{"key":"e_1_2_23_83_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200102013440503"},{"key":"e_1_2_23_84_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-002-2011-8"},{"key":"e_1_2_23_85_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650060915"},{"key":"e_1_2_23_86_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(03)90005-1"},{"key":"e_1_2_23_87_2","article-title":"Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis","author":"Chesnut CH","journal-title":"J Bone Miner Res"},{"key":"e_1_2_23_88_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-022029"},{"key":"e_1_2_23_89_2","first-page":"S209","article-title":"A new treatment paradigm: quarterly injections of ibandronate reduce the risk of fractures in women with postmenopausal osteoporosis (PMO): results of a 3\u2010year trial","volume":"11","author":"Recker R","year":"2000","journal-title":"Osteoporous Int"},{"key":"e_1_2_23_90_2","first-page":"S14","article-title":"Three\u2010monthly 2 mg intravenous ibandronate bolus injections significantly increase bone mineral density in women with postmenopausal osteoporosis","volume":"13","author":"Adami S","year":"2002","journal-title":"Osteoporous Int"},{"key":"e_1_2_23_91_2","article-title":"Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosis","author":"McClung MR","journal-title":"J Bone Miner Res"},{"key":"e_1_2_23_92_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.2003.01174.x"},{"key":"e_1_2_23_93_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.10.969"},{"key":"e_1_2_23_94_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.1999.14.9.1557"},{"key":"e_1_2_23_95_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011807"},{"key":"e_1_2_23_96_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200202283460902"},{"key":"e_1_2_23_97_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-2760(01)00460-X"},{"key":"e_1_2_23_98_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105103441904"},{"key":"e_1_2_23_99_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.6.2127"},{"key":"e_1_2_23_100_2","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2003.39.2.799416"},{"key":"e_1_2_23_101_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001980200129"},{"key":"e_1_2_23_102_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/39.12.1309"},{"key":"e_1_2_23_103_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8529(02)00024-5"},{"key":"e_1_2_23_104_2","unstructured":"McClungM BalskeA DaleyMet\u00a0al.Long\u2010term prevention of postmenopausal bone loss with alendronate. Effects of continuous treatment and after withdrawal.81st Annual Meeting of the Endocrine Society San Diego June 12\u201315 1999."}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2796.2004.01292.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2796.2004.01292.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T19:20:58Z","timestamp":1697138458000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2796.2004.01292.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5,14]]},"references-count":103,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["10.1111\/j.1365-2796.2004.01292.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2796.2004.01292.x","archive":["Portico"],"relation":{},"ISSN":["0954-6820","1365-2796"],"issn-type":[{"value":"0954-6820","type":"print"},{"value":"1365-2796","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5,14]]}}}